Tempest Minerals Ltd
- Country
- Ownership
- -
- Employees
- 6
- Market Cap
- -
- Introduction
Tempest Minerals Ltd is engaged in the exploration of precious metals, base metals, and energy metals. The projects include Range Project, Messenger Project, Rocky Hill Project, Warriedar and many more. The firm has one reportable segment, being the exploration of mineral projects in Western Australia. Geographically it operates in Australia, Zimbabwe and Mozambique and derives key revenue from Australia.
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
- Conditions
- Cancer
- First Posted Date
- 2024-01-16
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- Tempus AI
- Target Recruit Count
- 500
- Registration Number
- NCT06207032
- Locations
- 🇺🇸
Frederick Health Regional System, Frederick, Maryland, United States
🇺🇸Alabama Oncology, Birmingham, Alabama, United States
🇺🇸Eastern CT and Hematology and Oncology Associates, Norwich, Connecticut, United States
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients with Head & Neck Squamous Cell Carcinoma (HNSCC)
- Conditions
- Head and Neck Squamous Cell Carcinoma
- First Posted Date
- 2023-12-11
- Last Posted Date
- 2025-01-08
- Lead Sponsor
- Tempus AI
- Target Recruit Count
- 500
- Registration Number
- NCT06163534
- Locations
- 🇺🇸
Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
🇺🇸City of Hope, Duarte, California, United States
🇺🇸USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
Addressing Undertreatment and Health Equity in Aortic Stenosis Using an Integrated EHR Platform
- Conditions
- Aortic Valve StenosisMitral Regurgitation
- Interventions
- Behavioral: Automated alert
- First Posted Date
- 2023-10-25
- Last Posted Date
- 2024-10-15
- Lead Sponsor
- Tempus AI
- Target Recruit Count
- 2626
- Registration Number
- NCT06099665
- Locations
- 🇺🇸
Saint Luke's Health System, Kansas City, Missouri, United States
🇺🇸OhioHealth, Columbus, Ohio, United States
🇺🇸Bon Secours Mercy Health - Lima Market, Lima, Ohio, United States
Umbrella Study for Analysis of Data Related to Patients with Cancer
- Conditions
- Cancer
- First Posted Date
- 2023-08-31
- Last Posted Date
- 2024-12-31
- Lead Sponsor
- Tempus AI
- Target Recruit Count
- 10000
- Registration Number
- NCT06018753
- Locations
- 🇺🇸
Memorial Health Services, Fountain Valley, California, United States
🇺🇸Hawaii Cancer Care, Honolulu, Hawaii, United States
🇺🇸Illinois Cancer Care, Peoria, Illinois, United States
Electrocardiogram-based Artificial Intelligence-assisted Detection of Heart Disease
- Conditions
- Atrial FibrillationStructural Heart Disease
- Interventions
- Device: EchocardiogramDevice: Zio Patch Monitor
- First Posted Date
- 2022-07-01
- Last Posted Date
- 2024-07-25
- Lead Sponsor
- Tempus AI
- Target Recruit Count
- 1000
- Registration Number
- NCT05442203
- Locations
- 🇺🇸
Corewell Health, Grand Rapids, Michigan, United States
🇺🇸TriHealth, Cincinnati, Ohio, United States
🇺🇸Geisinger Medical Center, Danville, Pennsylvania, United States
Tempus Sculptor Study: Small Cell Lung Cancer (SCLC) Observational Study
- Conditions
- Small Cell Lung Cancer
- Interventions
- Other: Observation
- First Posted Date
- 2022-02-25
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Tempus AI
- Target Recruit Count
- 50
- Registration Number
- NCT05257551
- Locations
- 🇺🇸
Ohio State University, Columbus, Ohio, United States
🇺🇸Cancer and Blood Specialty Clinic, Los Alamitos, California, United States
🇺🇸University of Colorado, Aurora, Colorado, United States
GEMINI-NSCLC: NSCLC Biomarker Study
- Conditions
- Non-Small Cell Lung Cancer
- Interventions
- Other: Observation
- First Posted Date
- 2022-02-11
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Tempus AI
- Target Recruit Count
- 1200
- Registration Number
- NCT05236114
- Locations
- 🇺🇸
Frederick Health Regional System, Frederick, Maryland, United States
🇺🇸Icahn School of Medicine at Mount Sinai, New York, New York, United States
🇺🇸Alabama Oncology, Birmingham, Alabama, United States
Tempus CRC Surveillance Study: a CtDNA Biomarker Profiling Study of Patients with CRC Using NGS Assays
- Conditions
- Colorectal Cancer
- Interventions
- Other: Observation
- First Posted Date
- 2022-02-10
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Tempus AI
- Target Recruit Count
- 160
- Registration Number
- NCT05234177
- Locations
- 🇺🇸
Mercy Clinic Oncology - Fort Smith, Fort Smith, Arkansas, United States
🇺🇸MemorialCare, Fountain Valley, California, United States
🇺🇸The Center for Cancer and Blood Disorders, Bethesda, Maryland, United States
Tempus Priority Study: A Pan-tumor Observational Study
- Conditions
- Breast CancerOvarian CancerCancer of Head and NeckCancer of Gastrointestinal TractCancer of KidneyLymphomaBladder CancerBrain CancerPancreatic CancerFallopian Tube Cancer
- Interventions
- Other: Observation
- First Posted Date
- 2022-01-05
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- Tempus AI
- Target Recruit Count
- 1000
- Registration Number
- NCT05179824
- Locations
- 🇺🇸
UT Southwestern, Dallas, Texas, United States
🇺🇸Baylor College of Medicine, Houston, Texas, United States
Niraparib in the Treatment of Patients with Advanced PALB2 Mutated Tumors
- Conditions
- Solid TumorBreast TumorColon Tumor, MalignantUrologic CancerMelanomaMetastatic CancerLung TumorHead and Neck CancerPancreatic CancerEsophageal Cancer
- Interventions
- First Posted Date
- 2021-12-27
- Last Posted Date
- 2024-09-30
- Lead Sponsor
- Tempus AI
- Target Recruit Count
- 22
- Registration Number
- NCT05169437
- Locations
- 🇺🇸
Yuma Regional Medical Center, Yuma, Arizona, United States
🇺🇸Northwest Oncology & Hematology, Rolling Meadows, Illinois, United States
🇺🇸St Joseph Heritage Health - Fullerton, Fullerton, California, United States